aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with a mission to revolutionize personalized medicine, Aquavit Pharmaceuticals focuses on discovering, developing, and commercializing innovative pharmaceuticals, medical devices, and health technologies. The company aims to enhance patient health and optimize medical community efficiency through a diverse approach that addresses significant unmet needs. Their product pipeline spans multiple specialties, including neuroscience, oncology, medical dermatology, medical aesthetics, and immunology (COVID-19).
Aquavit Pharmaceuticals has garnered attention for its pioneering work in personalized healthcare delivery systems. The company collaborates with leading experts and investors in the healthcare sector to drive its mission forward. Notable achievements include advancements in early-stage to commercialization phases across various medical fields. Aquavit's impact is evident in its commitment to modernizing healthcare and improving patient outcomes through cutting-edge solutions.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices, Pharmaceuticals
Technology
HealthTech, Biotech
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
Global
When was Aquavit Pharmaceuticals founded?
Aquavit Pharmaceuticals was founded in 2010.
Where is Aquavit Pharmaceuticals’s headquarters located?
Aquavit Pharmaceuticals’s headquarters is located in New York City, NY, US.
When was Aquavit Pharmaceuticals’s last funding round?
Aquavit Pharmaceuticals’s most recent funding round was for $330k (USD) in December 2012.
How many employees does Aquavit Pharmaceuticals have?
Aquavit Pharmaceuticals has 15 employees as of Feb 4, 2024.
How much has Aquavit Pharmaceuticals raised to-date?
As of July 05, 2023, Aquavit Pharmaceuticals has raised a total of $330k (USD) since Dec 30, 2012.
Add Comparison
Total Raised to Date
$330k
USD
Last Update Dec 30, 2012
Last Deal Details
$330k
USD
Dec 30, 2012
Series Unknown
Total Employees Over Time
15
As of Feb 2024
Aquavit Pharmaceuticals Address
New York Ave
New York City,
New York
11217
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts